Animal models in syndromes of accelerated arteriosclerosis

Annals of Vascular Surgery

Volumn 13, Issue 3, 1999, Pages 328-338

  Wolf, Yehuda G ^a   Gertz, S David ^b,c   Banai, Shmuel ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEBREW UNIVERSITY   (Israel)

^c BIKUR CHOLIM HOSPITAL   (Israel)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; DISEASE ASSOCIATION; DOG; HYPERPLASIA; NONHUMAN; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; SYNDROME;

EID: 0032899792     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0890-5096(06)61774-3     Document Type: Article

References (133)

1. Topol EJ, Leya F, Pinkerton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993; 329:221-227.
2. Adelman AG, Cohen BA, Kimball BP, et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending artery. N Engl J Med 1993;329:228-233.
3. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
4. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
5. Chervu A, Moore WS. An overview of intimal hyperplasia. Surg Gynecol Obstet 1990;171:433-437.
6. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologie observations in 20 patients. J Am Coll Cardiol 1991; 17:433-439.
7. Mak KH, Topol EJ. Clinical trails to prevent restenosis after percutaneous revascularization. Ann NY Acad Sci 1997; 811:255-284.
8. Powell JS, Clozel J-P, Muller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
9. Clozel JP, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension 1991;18(Suppl 4):I-155-I159.
10. Lam JYT, Lacoste L, Bourassa Mg. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992;85:1542-1547.
11. Hanson SR, Powell JS, Dodson T, et al. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991;18(Suppl 4):II-70-II-76.
12. The MERCATOR Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86: 100-110.
13. Faxon DP for the MARCATOR Study Group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:362-369.
14. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. 1. Smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-333.
15. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983;49:208-215.
16. Imparato AM, Bracco A, Kim GE, Zeff R. Intimal and neointimal fibrous proliferation causing failure of arterial reconstruction. Surgery 1972;72:1007-1017.
17. Lytle BW, Loop FD, Cosgrove DM, et al. Long-term serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 1985;89: 248-258.
18. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol 1994;9:641-649.
19. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989;80:1726-1736.
20. Zierler RE, Bandyk DF. Carotid artery stenosis following carotid endarterectomy. Arch Surg 1982;117:1408-1415.
21. Greenwood LH, Hallett JW, Yrizarry JM, Robison JG, Brown SB. Diffuse arterial narrowing after thromboembolectomy with the Fogarty balloon catheter. AJR Am J Roentgenol 1984;142:141-142.
22. Hong MK, Mehran R, Mintz GS, Leon MB. Restenosis after coronary angioplasty. Curr Prob Cardiol 1997;22.
23. Potkin BN, Roberts WC. Effects of percutaneous coronary angioplasty on atherosclerotic plaques and relation of plaque composition and external size to outcome. Am J Cardiol 1988;62:41-50.
24. Rodriguez A, Santaera O, Larribeau M, Sosa MI, Palacios IF. Early decrease in minimal luminal diameter after successful percutaneous transluminal coronary angioplasty predicts late restenosis. Am J Cardiol 1993;71:1391-1395.
25. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post-PTCA restenosis: dependence on lesion substrate. Thromb Haemost 1995;74:552-559.
26. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 1997;96:475-483.
27. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation 1994;89:2816-2821.
28. Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation 1996;93: 1717-1724.
29. Gertz SD, Gimple LW, Banai S, et al. Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic histomorphometric studies of atherosclerotic arteries in rabbits. Circulation 1994;90:3001-3008.
30. Palmaz JC, Sibbit RR, Tio FO, Rentes SR, Peters JE, Garcia F. Expandable intraluminal vascular graft: a feasibility study. Surgery 1986;99:199-205.
31. Painter JA, Mintz GS, Wong SC, et al. Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil. Am J Cardiol 1995;75:398-400.
32. Gordon PC, Gibson CM, Cohen DJ, Carrozza JP, Kuntz RE, Baim DS. Mechanisms of restenosis and redilation within coronary stents - quantitative angiographic assessment. J Am Coll Cardiol 1993;21:1166-1174.
33. Gertz SD, Gimple LW, Ragosta M, et al. Response of femoral arteries of cholesterol-fed rabbits to balloon angioplasty with and without laser: emphasis on the distribution of foam cells. Exp Mol Pathol 1993;59:225-243.
34. Schwartz SM, Edward DDB, O'Brien RM. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995;77:445-465.
35. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1993;73:223-231.
36. Wolf YG, Rasmussen LM, Rhuoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994;93:1172-1178.
37. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PN. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-658.
38. Riessen R, Isner JM, Blessing E, Loushin C, Nikol S, Wight TN. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994;144:962-974.
39. Rasmussen LM, Wolf YG, Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-β activity. Am J Pathol 1995;147:1041-1048.
40. Wolinsky H, Glagov S. A lamellar unit of aortic medial structure and function in mammals. Circ Res 1967;20:99-111.
41. Sims FH. A comparison of structural features of the walls of coronary arteries from 10 different species. Pathology 1989;21:115-124.
42. Sims FH, Gavin JB, Vanderwee MA. The intima of human coronary arteries. Am Heart J 1989;118:32-38.
43. Reidy MA. Arterial lesion development: balloon catheter injury and smooth muscle cell proliferation. J Vasc Surg 1995;22:89-91.
44. Block PC, Baughman KL, Pasternack RC, Fallon JT. Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model. Circulation 1980;61:778-785.
45. Armstrong ML, Heistad DD. Animal models of atherosclerosis. Atherosclerosis 1990;85:15-23.
46. Prescott MF, McBride CH, Rapacz JH, Linden JV, Rapacz J. Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 1991;139:139-147.
47. Vesselinovitch D. Animal models and the study of atherosclerosis. Arch Pathol Lab Med 1988;112:1011-1017.
48. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418-432.
49. Mason R, Read M. Some species differences in fibrinolysis and blood coagulation. J Biomed Mater Res 1971;5:121-128.
50. Lindner V, Fingerie J, Reidy MA. Mouse model of arterial injury. Circ Res 1993;73:792-796.
51. Ozaki CK, Farrehi PM, Fay WP, Stanley JC. Novel murine arterial injury model. Circulation 1996;94(Suppl I):2347A.
52. Carmeliet P, Moons L, Stassem J-M, et al. A model for arterial neointima formation using perivascular electric injury in mice. Am J Pathol 1997;150:761-767.
53. Moroi M, Gold HK, Yasuda T, Fishman MC, Huang PL. Mice mutant in endothelial litric oxide synthase: vessel growth and response to injury. Circ 1996;94(Suppl I):154.
54. Festing MFW, May D, Connors TA, Lovell D, Sparrow S. An athymic nude mutation in the rat. Nature 1978;274: 365-366.
55. Paul M, Wagner J, Hoffman S, Urata H, Barter D. Transgenic rats: new experimental models for the study of candidate genes in hypertension research. Annu Rev Physiol 1994;56:811-829.
56. Gross DR. Animal Models in Cardiovascular Research. Boston: Martinus Niihoff, 1985, pp 537-547.
57. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured carotid artery. Circ Res 1985;56:139-145.
58. Fishman JA, Rayan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in pathogenesis of myointimal thickening. Lab Invest 1975;32:339-351.
59. Umemura K, Watanabe S, Kondo K, Hashimoto H, Nakashima M, Inhibitory effect of prostaglandin E1 on intimal thickening following photochemically induced endothelial injury in the rat femoral artery. Atherosclerosis 1997;130: 11-16.
60. Capron L, Jarnet J, Heudes D, Joseph-Monrose D, Bruneval P. Repeated balloon injury of the rat aorta. A model of neointima with attenuated inhibition by heparin. Arterioscler Thromb Vasc Biol 1997;17:1649-1656.
61. Saenz NC, Hendren RB, Schoof DD, Folkman J. Reduction of smooth muscle hyperplasia in vein grafts in athymic rats. Lab Invest 1991;65:115-122,
62. Roux SP, Clozel JP, Kuhn H. Cilazapril inhibits wall thickening of vein bypass grafts in the rat. Hypertension 1991;18(Suppl II):43-46.
63. Baumgartner HR. Eine neue Methode zur Erzeugung von Thromben durch gezieite Ueberdehnung der Gefasswand. Z Ges Exp Med 1963;137:227.
64. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS. Cellular pathology of progressive atherosclerosis in the WHHL rabbit: an animal model of familial hypercholesterolemia. Arteriosclerosis 1983;3:87-101.
65. Faxon DP, Sanborn TA, Weber VJ, et al. Restenosis following transluminal angioplasty in experimental atherosclerosis. Arteriosclerosis 1984;4:189-195.
66. Palmaz JC, Windeler SAM, Garcia FM, Tio FO, Sibbitt RR, Reuter SR. Atherosclerotic rabbit aortas: expandable intraluminal grafting. Radiology 1986;160:723-726.
67. Sarembock I. The limitations of the rabbit athero/injury model. J Vasc Surg 1995;22:93-94.
68. Nguyen HC, Steinberg BM, LeBoutillier M, et al. Suppression of neointimal lesions after vascular injury: a role for polyclonal anti-basic fibroblast growth factor antibody. Surgery 1994;116:456-462.
69. Sarembock IJ, La Veau PJ, Sigal SL, et al. Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty. Circulation 1989;80:1029-1040.
70. Nielsen LB, Stender S, Kjeldsen K, Nordesgard BG. Specific accumulation of lipoprotein (a) in balloon-injured rabbit aorta in vivo. Circ Res 1996;78:615-626.
71. Jamal A, Bendeck M, Langille BL. Structural changes and recovery of function after arterial injury. Arterioscler Thromb 1992;12:307-317.
72. Doomekamp FNG, Borst C, Haudenschild CC, Post MJ. Fogarty and percutaneous transluminal coronary angioplasty balloon injury induce comparable damage to the arterial wall but lead to different healing responses. J Vasc Surg 1996;24:843-850.
73. Banai S, Shou M, Correa R, et al. Rabbit ear model of injury-induced arterial smooth muscle cell proliferation. Circ Res 1991;69:748-756.
74. Moore S. Thromboatherosclerosis in normolipemic rabbits: a result of continued endothelial damage. Lab Invest 1973; 29:478-487.
75. O'Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen P. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg 1991; 214:727-732.
76. Betz E, Schlote W. Responses of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979;74:10-20.
77. LeVeen RF, Wolf GL, Villanueva TG. New rabbit atherosclerosis model for the investigation of transluminal angioplasty. Invest Radiol 1982;17:470-475.
78. Kockx MM, De Meyer GR, Jacob WA, Bult H, Herman AG. Triphasic sequence of neointmal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb 1992;12: 1447-1457.
79. Crea C, Abela GS, Fenech A, Smith W, Pepine CJ, Conti CR. Transluminal laser irradiation of coronary arteries in live dogs: an angiographic and morphologic study of acute effects. Am J Cardiol 1985;57:171-174.
80. Schatz RA, Palmaz JC, Tio FO, Garcia S, Garcia O, Reuter SR. Balloon expandable intracoronary stents in the adult dog. Circulation 1987;76:450-456.
81. Roubin GS, Robinson KA, King SB, et al. Early and late results of intracoronary arterial stenting after angioplasty in dogs. Circulation 1987;76:891-898.
82. Geer JC, Guidry MA. Experimental canine atherosclerosis. In: Roberts JC Jr, Straus R, eds. Comparative Atherosclerosis: The Morphology of Spontaneous and Induced Atherosclerotic Lesions in Animals and Its Relation to Human Disease. New York: Harper & Row, 1965, pp 170-185.
83. Schwartz RS, Edwards WD, Bailey KB, Camrud AR, Jorgenson MA, Holmes DR. Differential neointimal response to coronary artery injury in pigs and dogs. Arterioscler Thromb 1994;14:395-400.
84. Schwarcz TH, Dobrin PB, Mrvicka R, Skowron L, Cole MB. Early myointimal hyperplasia after balloon catheter embolectomy: effect of shear forces and multiple withdrawals. J Vasc Surg 1988;7:495-499.
85. Zollikofer CL, Redha FH, Bruhlman FH, et al. Acute and long-term effects of massive balloon dilatation on the aortic wall and vasa vasorum. Radiology 1987;164:145-149.
86. Chen C, Hughes JD, Mattar SG, Ku DN, Lumsden AB. Time-course study of intimal hyperplasia in the endarterectomized canine artery. J Surg Res 1997;67:106-112.
87. Fillinger MF, Reinitz ER, Schwartz RA, et al. Graft geometry and venous intimal-medial hyperplasia in arteriovenous loop grafts. J Vasc Surg 1990;11:556-566.
88. Cevallos WH, Holmes WL, Myers RN, Smink RD. Swine in atherosclerosis research: development of an experimental animal model and study of the effect of dietary fats on cholesterol metabolism. Atherosclerosis 1979;34:303-317.
89. French JE, Jennings MA, Florey HW. Morphological studies on atherosclerosis in swine. Ann NY Acad Sci 1965;127: 780-794.
90. Leach CM, Thorburn GD. A comparative study of collagen-induced thromboxane release from platelets of different species: implications for human atherosclerosis models. Prostaglandins 1982;24:47-59.
91. Griggs TR, Reddick RL, Sultzer D, Brinkhous KM. Susceptibility to atherosclerosis in aortas and coronary arteries of swine with von Willebrand's disease. Am J Pathol 1981; 102:137-145.
92. Lam JY, Chesebro JH, Steele PM, et al. Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs. Circulation 1991;84:814-820.
93. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vliestra RE, Holmes DR. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200.
94. Muller CA, Opie LH, Hamm CW, Peisach M, Pineda CA, Thandroyen FT. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Circulation 1988;78:227-232.
95. Steele PM, Chesebro JH, Stanson AW, et al. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-112.
96. Banai S, Wolf Y, Golomb G, et al. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation 1998; 97:1960-1969.
97. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg KA, King SB. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol 1992;20:467-474.
98. Rudel LL. Plasma lipoproteins in atherogenesis in nonhuman primates. In: Kalter S, ed. The Use of Non-human Primates in Cardiovascular Disease. Austin, TX: University of Texas Press, 1980, pp 37-55.
99. Clarkson TB, Prichard RW, Bullock BC, et al. Pathogenesis of atherosclerosis: some advances from using animal models. Exp Mol Pathol 1976;24:264-286.
100. Wissler RW, Vesselinovitch D. Experimental models of human atherosclerosis. Ann NY Acad Sci 1968;149:907-922.
101. Mondy JS, Williams JK, Adams MR, Dean RH, Geary RL. Structural determinants of lumen narrowing after angioplasty in atherosclerotic nonhuman primates. J Vasc Surg 1997;26:875-883.
102. Wissler RW. Advantages and shortcomings of animal models in atherosclerosis research. J Vasc Surg 1994;20:114-116.
103. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of heparin to inhibit hyperplasia in injured baboon arteries. Circulation 1995;91:2972-2981.
104. Krupski WC, Bass A, Kelly AB, Hanson SR, Harker LA. Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries. Circulation 1991;84:1749-1757.
105. Lesniewska BB, Zimmerman MTD, Odermatt BF, Briner J, Heitz PU, Zimmerman DR. Distribution of large aggregating proteoglycan versican in adult human tissue. J Histochem Cytochem 1996;44:303-312.
106. Kacem K, Seylaz J, Aubineau P. Differential processes of vascular smooth muscle cell differentiation within elastic and muscular arteries of rats and rabbits: an immunofluorescence study of desmin and vimentin distribution. Histochem J 1996;28:53-61.
107. Chong WK, Lawrence R, Gardener J, Lees WR. The appearance of normal and abnormal arterial morphology on intravascular ultrasound. Clin Radiol 1993;48:301-306.
108. Hansen DD, Auth DC, Vrocko R, Ritchie JL. Rotational atherectomy in atherosclerotic rabbit iliac arteries. Am Heart J 1988;115:160-165.
109. Buchwald AB, Unterberg C, Nebendahl K, Grone HJ, Wiegand V. Low-molecular-weight heparin reduces neointimal proliferation after coronary stent implantation in hypercholesterolemic minipigs. Circulation 1992;86:531-537.
110. Strauss BH, Chrisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodelling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-658.
111. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. Arterioscler Thromb Vasc Biol 1996;16:34-43.
112. Koyama H, Reidy MA. Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2. Circ Res 1997;80:408-417.
113. Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19:267-274.
114. Bonan R, Paiement P, Scortichini D, Cloutier M-J, Leung TK. Coronary restenosis: evaluation of a restenosis injury index in a swine model. Am Heart J 1993;126:1334-1340.
115. Schwartz RS, Holmes DR. Pigs, dogs, baboons and man: lessons for stenting from animal studies. J Intervent Cardiol 1994;7:355-368.
116. Clowes AW, Clowes MM, Fingerle J, Reidy MA. Kinetics of cell proliferation after arterial injury: V. Role of acute distention in the induction of smooth muscle proliferation. Lab Invest 1989;60:360-364.
117. Lindner V, Reidy MA, Fingerle J. Regrowth of arterial endothelium. Denudation with minimal trauma leads to complete endothelial regrowth. Lab Invest 1989;61:556-563.
118. Bilder GE, Kasiewski CJ, Costello RJ, Hodge TG, Perrone MH. Electrode cuff-induced changes in DNA and PDGF gene expression in the rat carotid artery. Atherosclerosis 1993;100:103-112.
119. Brown DM, Kanaia NM, Choi ET, et al. Local irrigation with tissue factor pathway inhibitor inhibits intimai hyperplasia induced by arterial interventions. Arch Surg 1996; 131:1086-1090.
120. Chignier E, Eloy R. Adventitial resection of small artery provokes endothelial loss and intimal hyperplasia. Surg Gynecol Obstet 1986;163:327-334.
121. Lincoff MA, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis. Fact, fancy and future. Circulation 1994;90:2070-2084.
122. Lovich MA, Brown L, Edelman ER. Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery. J Am Coll Cardiol 1997;29:1645-1650.
123. Wolf YG, Rasmussen LM, Sherman Y, Bundens WP, Hye RJ. Nitroglycerin decreases medial smooth muscle cell proliferation after arterial balloon injury. J Vasc Surg 1995;21: 499-504.
124. Orloff LA, Glenn MG, Domb AJ. Esclamado RA. Prevention of venous thrombosis in microvascular surgery by transmural release of heparin from a polyanhydride polymer. Surgery 1995;117:554-559.
125. Brauner R, Laks H, Drinkwater DC Jr, et al. Controlled periadventitial administration of verapamil inhibits neointimal smooth muscle cell proliferation and ameliorates vasomotor abnormalities in experimental vein bypass grafts. J Thorac Cardiovasc Surg 1997;114:53-63.
126. Wolinsky H. Local delivery: let's keep our eyes on the wall. J Am Coll Cardiol 1994;24:825-827.
127. Plante S, Dupuis G, Mongeau CJ, Durand P. Porous balloon catheters for local delivery: assessment of vascular damage in a rabbit iliac angioplasty model. J Am Coll Cardiol 1994; 24:820-824.
128. Wolinsky H, Thung SN. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1990;15:475-481.
129. Lincoff AM, Furst JG, Penn MS, et al. Efficiency of solute transfer by a microporous balloon catheter in the procine coronary model of arterial injury. J Am Coll Cardiol 1994; 23:118A.
130. Teirstein PS, Masullo V, Jani S, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703.
131. Hehrlein C, Gollan C, Dongens K, et al. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995;92:1570-1575.
132. Waksman R, Robinson KA, Crocker IR, et al. Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation 1995;92:3025-3031.
133. De Young MB, Dichek DA. Gene therapy for restenosis. Are we ready? Circ Res 1998;82:306-313.